BMJ  2005;330:1025 (30 April), doi:10.1136/bmj.330.7498.1025-a

Letter

Reduction in mortality from breast cancer

Reasons for improved survival are more complex than suggested

The first 150 words of the full text of this article appear below.

EDITOR—Although no supporting data are given, Jones in her editorial proposes that adjuvant treatments with chemotherapy or hormones are more likely than screening to be responsible for reduction in breast cancer mortality.¹ However, the reason(s) for the improved survival is much more complex than suggested.

In the 1970s surgeons felt they "owned" the patient and were usually the only ones who decided which women had anything other than surgery. Nowadays it is accepted that overall management is best decided by a multidisciplinary team and that several people—medical and non-medical—have a crucial role in the management. This very basic change in the overall management of breast and other cancers has been overlooked in the rush to promote the use of adjuvant chemotherapy, although its benefit has been very much over-rated.¹

Additionally the editorial does not give due credit to radiotherapy—there is now evidence that its omission after mastectomy even . . . [Full text of this article]

Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW 2065, Australia gmorgan1@bigpond.net.au

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Reduction in mortality from breast cancer

Alison L Jones
BMJ 2005 330: 205-206. [Extract] [Full Text] [PDF]